Bussian et al. used MAPTP301S PS19 mouse model of tau-dependent neurodegenerative disease to investigate whether the depletion of senescent cells via ABT-263 ameliorates the tau-dependent pathology while preserving cognitive function (Bussian et al., 2018). Here, MAPT is linked to neurodegenerative disease.